TOMI Environmental Solutions Highlights SteraMist Efficacy in Neutralizing Biohazards Amid Rising Hantavirus Concerns

TOMI Environmental Solutions (NASDAQ: TOMZ) highlights its SteraMist iHP technology as an effective remediation tool against rodent-borne pathogens including hantavirus amid a recent cruise-ship outbreak (six cases, three fatalities as of May 6, 2026).

Rhea-AI Summary

TOMI Environmental Solutions (NASDAQ: TOMZ) highlights its SteraMist iHP technology as an effective remediation tool against rodent-borne pathogens including hantavirus amid a recent cruise-ship outbreak (six cases, three fatalities as of May 6, 2026).

SteraMist is described as an ionized hydrogen peroxide fog that penetrates structures, is non-corrosive, and targets enveloped viruses by oxidizing their lipid membranes, enabling rapid decontamination and faster re-entry for high-risk environments.

Positive

• SteraMist iHP targets enveloped viruses via oxidative destruction
• Non-corrosive fog permits rapid re-entry after treatment
• Designed for complete penetration of structural spaces
• Positioned for use in specialized biohazard and restoration sectors

Negative

• News cites a hantavirus outbreak with 6 cases and 3 fatalities
• Seasonal rodent movement increases zoonotic disease risk
• Remediation requires professional-grade response and trained personnel

Argus May 8 session

+16.22% close to close Open Argus

Details

News Market Reaction – TOMZ

On May 8, the first trading day after this news, TOMZ closed 16.22% above the previous close.

Data tracked by StockTitan Argus for the May 8 session.

Key Figures

Q1 2026 prelim revenue: $1.7 million Sequential revenue growth: 67% 2025 sales: $5.64 million +5 more

Q1 2026 prelim revenue

$1.7 million

Unaudited preliminary revenue for Q1 2026

Sequential revenue growth

67%

Q1 2026 vs Q4 2025 revenue increase

2025 sales

$5.64 million

Full-year 2025 sales, down from $7.74 million

2025 net loss

$3.75 million

Net loss for 2025, or $0.19 per share

BIT Solution 2025 sales

$1,065,172

BIT Solution sales in 2025

Q1 2026 total orders

$3.36 million

First-quarter 2026 total orders and open orders

S-3 shelf size

$50,000,000

Maximum aggregate offering under S-3 shelf registration

Hantavirus cases and fatalities

6 cases, 3 fatalities

Reported aboard an Atlantic cruise ship as of May 6, 2026

Historical Context

5 past events · Latest: Apr 30

5 events

1. Apr 30

   Merger LOI

   24h Move

   -8.2%

   Non-binding LOI to merge with Carbonium Core valued at $120M.

2. Apr 29

   Strategic pivot

   24h Move

   +10.5%

   Plan to integrate SteraMist iHP into autonomous defense platforms.

3. Apr 28

   Investor presentation

   24h Move

   -4.4%

   NEXT SUPER STOCK livestream presentation and operations update.

4. Apr 27

   Trade show update

   24h Move

   +13.5%

   Strong INTERPHEX interest and timelines with a major healthcare customer.

5. Apr 22

   Product upgrade

   24h Move

   +8.7%

   Redesign of SteraMist robot into autonomous SteraBot product line.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

ionized Hydrogen Peroxide (iHP), enveloped virus, zoonotic diseases, biohazard

4 terms

ionized Hydrogen Peroxide (iHP) medical

"TOMI’s ionized Hydrogen Peroxide (iHP) technology is highly effective..."

Ionized hydrogen peroxide (IHP) is a form of hydrogen peroxide that has been transformed into a charged, active state, making it more effective at killing germs and breaking down contaminants. Its enhanced properties can lead to improved cleaning and disinfecting performance, which may influence industries such as healthcare, sanitation, and manufacturing. For investors, understanding IHP is important because advancements or increased demand for its use can impact companies involved in producing or applying this technology.

enveloped virus medical

"Because hantaviruses are an enveloped virus, they possess a fragile outer..."

A virus surrounded by an outer lipid membrane (envelope) that it borrows from the host cell; this membrane carries proteins that help the virus enter new cells. The envelope makes these viruses more sensitive to drying, soap, and disinfectants but often better at evading immune defenses, which affects how easily they spread, how long they survive on surfaces, and what kinds of treatments or vaccines are effective—factors investors watch for product demand, manufacturing, and regulatory hurdles.

zoonotic diseases medical

"increasing the risk of zoonotic diseases spread between animals and humans."

Diseases that can jump from animals to humans, like a bug that normally lives in wildlife or livestock but spreads to people. Investors care because such outbreaks can disrupt supply chains, reduce consumer demand, trigger travel or trade restrictions, and prompt sudden regulatory or healthcare spending; think of it as a factory fire in one part of the economy that creates ripple effects across many businesses and costs.

biohazard medical

"The presence of SteraMist in specialized biohazard and restoration sectors..."

Material, substance, or area that contains biological agents or contaminated items capable of causing disease or environmental harm, such as infected tissue, cultures, or contaminated medical waste. It matters to investors because biohazards can force facility closures, trigger costly cleanup and regulatory action, increase legal and insurance exposure, and damage reputation—similar to how a fire risk can stop a factory and harm a company’s finances and operations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FREDERICK, Md., May 07, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today reinforces the critical role of its SteraMist iHP disinfection technology in addressing the escalating public health risks associated with rodent-borne pathogens, including Hantavirus. As of May 6, 2026, international health authorities are responding to a rare hantavirus outbreak aboard an Atlantic cruise ship, with six cases identified and three fatalities reported. Seasonal shifts drive rodents into residential and commercial structures, increasing the risk of zoonotic diseases spread between animals and humans. Hantavirus, primarily transmitted through contact with infected rodent excreta, poses a severe respiratory threat requiring professional-grade remediation.

TOMI’s ionized Hydrogen Peroxide (iHP) technology is highly effective against these threats. Because hantaviruses are an enveloped virus, they possess a fragile outer lipid membrane that is highly susceptible to the oxidative destruction of SteraMist's iHP technology. SteraMist iHP ensures a rapid, non-corrosive, and thorough solution for remediating environments contaminated by hazardous animal waste. The SteraMist iHP fog penetrates every area of a structure, achieving a complete kill of biological threats.

“The current public health landscape requires advanced technology capable of neutralizing sophisticated biological threats with speed and precision,” stated Dr. Halden Shane, CEO of TOMI Environmental Solutions. “SteraMist provides an essential layer of protection for high-risk environments, ensuring that structures are returned to a safe state through a process that is both scientifically validated and environmentally responsible. Is very important for the custodian, and/or cleaning personnel to be well protected and to make sure that they don’t aerosolize the droppings during sweeping and cleaning processes, which leads to increased levels of infection outbreaks.”

The presence of SteraMist in specialized biohazard and restoration sectors reflects its position as a preferred choice for professionals managing high-stakes environmental safety. Urban sprawl and climate patterns increase human-wildlife interactions, growing the demand for validated, rapid-deployment decontamination technology. SteraMist provides a superior alternative to traditional cleaning methods, allowing for quick re-entry and minimal business interruption. TOMI remains committed to innovating for a safer world through the global expansion of its disinfection platform.

About TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.

Forward-Looking Statements

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products and services. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:  

John Nesbett/Zach Nevas 
IMS Investor Relations 
tomi@imsinvestorrelations.com  

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How does TOMI's SteraMist iHP neutralize hantavirus for TOMZ shareholders?

SteraMist iHP oxidizes the lipid membrane of enveloped viruses, rendering them inactive within treated spaces. According to TOMI, the ionized hydrogen peroxide fog penetrates structure crevices, providing a non-corrosive, validated method for rapid decontamination in high-risk environments.

What did TOMI (TOMZ) say about the recent cruise-ship hantavirus outbreak on May 6, 2026?

TOMI highlighted increased demand for professional remediation after a cruise-ship outbreak reporting six cases and three fatalities as of May 6, 2026. According to TOMI, such events underscore the role of validated decontamination technologies in public-health responses.

Can SteraMist treatments allow quick re-entry to buildings after hantavirus remediation for TOMZ customers?

SteraMist is described as a rapid, non-corrosive decontamination process that supports quicker re-entry compared with some traditional methods. According to TOMI, its iHP fog minimizes downtime while aiming to achieve comprehensive biological kill in treated areas.

What precautions does TOMI recommend for custodians and cleaning personnel handling hantavirus-contaminated sites?

TOMI recommends professional-grade remediation and protective measures to avoid aerosolizing rodent droppings during cleaning. According to TOMI, trained personnel should follow containment and remediation protocols to reduce exposure and prevent increased infection risk.